Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma. | Front Oncol | 2022 | 36439516 | PubTator, text mining | PubMed |
| Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma. | Front Genet | 2022 | 36437916 | PubTator, text mining | PubMed |
| Retrospective Analysis of Prognostic Factors in Pediatric Patients with Adrenocortical Tumor from Unique Tertiary Center with Long-Term Follow-Up. | J Clin Med | 2022 | 36431124 | PubTator, text mining | PubMed |
| Assessment of RACGAP1 as a Prognostic and Immunological Biomarker in Multiple Human Tumors: A Multiomics Analysis. | Int J Mol Sci | 2022 | 36430577 | PubTator, text mining | PubMed |
| The Analysis of Relevant Gene Networks Based on Driver Genes in Breast Cancer. | Diagnostics (Basel) | 2022 | 36428940 | PubTator, text mining | PubMed |
| BUBR1 as a Prognostic Biomarker in Canine Oral Squamous Cell Carcinoma. | Animals (Basel) | 2022 | 36428310 | PubTator, text mining | PubMed |
| Prenatal diagnosis and molecular cytogenetic characterization of a de novo duplication of 2q12.2→q13 encompassing MALL, NPHP1, RGPD6 and BUB1. | Taiwan J Obstet Gynecol | 2022 | 36427971 | PubTator, text mining | PubMed |
| C118P exerted potent anti-tumor effects against melanoma with induction of G2/M arrest via inhibiting the expression of BUB1B. | J Dermatol Sci | 2022 | 36424293 | PubTator, text mining | PubMed |
| Clinical Applications of Aneuploidies in Evolution of NSCLC Patients: Current Status and Application Prospect. | Onco Targets Ther | 2022 | 36388157 | PubTator, text mining | PubMed |
| Integrated analyses of the methylome and transcriptome to unravel sex differences in the perirenal fat from suckling lambs. | Front Genet | 2022 | 36386829 | PubTator, text mining | PubMed |
| SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma. | Biomark Res | 2022 | 36380369 | PubTator, text mining | PubMed |
| Topological implications of DNA tumor viral episomes. | BMB Rep | 2022 | 36379513 | PubTator, text mining | PubMed |
| FADD as a key molecular player in cancer progression. | Mol Med | 2022 | 36348274 | PubTator, text mining | PubMed |
| Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma. | BMC Gastroenterol | 2022 | 36344926 | PubTator, text mining | PubMed |
| Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors. | Front Oncol | 2022 | 36338682 | PubTator, text mining | PubMed |
Loss of Brca1 and Trp53 in adult mouse mammary ductal epithelium results in development of hormone receptor-positive or hormone receptor-negative tumors, depending on inactivation of Rb family proteins. | Breast Cancer Res | 2022 | 36333737 | PubTator, text mining | PubMed |
| LncRNA CCTT-mediated RNA-DNA and RNA-protein interactions facilitate the recruitment of CENP-C to centromeric DNA during kinetochore assembly. | Mol Cell | 2022 | 36332605 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Integrated single-cell and transcriptome sequencing analyses determines a chromatin regulator-based signature for evaluating prognosis in lung adenocarcinoma. | Front Oncol | 2022 | 36324565 | PubTator, text mining | PubMed |
| Biallelic germline mutations in MAD1L1 induce a syndrome of aneuploidy with high tumor susceptibility. | Sci Adv | 2022 | 36322655 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=27